Sjoerd Hovenga

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

Annemieke Cats, Edwin P. M. Jansen, Nicole C.T. van Grieken et al. · The Lancet Oncology · 2018 · 562 citations

Surgical Oncology, Chemotherapy Versus Chemoradiotherapy, Gastrointestinal Oncology +8

Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial

Vivianne C. G. Tjan‐Heijnen, Irene E.G. van Hellemond, Petronella G.M. Peer et al. · The Lancet Oncology · 2017 · 157 citations

Medicine, Clinical Trials, Gynecology +10

CD27 is heterogeneously expressed in multiple myeloma: low CD27 expression in patients with high‐risk disease

Jeroen E. J. Guikema, Sjoerd Hovenga, Edo Vellenga et al. · British Journal of Haematology · 2003 · 97 citations · Full text

Progression of a solitary plasmacytoma to multiple myeloma. A population‐based registry of the northern Netherlands

Esther G.M. De Waal, Marnix J. Leene, Nic J.G.M. Veeger et al. · British Journal of Haematology · 2016 · 78 citations · Full text

Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses: a high incidence of oligoclonal serum Igs post transplantation

Sjoerd Hovenga, JThM de Wolf, Harry Klip et al. · Bone Marrow Transplantation · 2000 · 59 citations

Cell Therapy, Transplantation, Autoimmune Disease +12